Healthcare provider profile · identity verified

James T Hardee, MD

Internal Medicine · WESTMINSTER, CO · NPI 1134256720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	828	226
Omeprazole	Omeprazole	469	134
Lisinopril	Lisinopril	416	119
Simvastatin	Simvastatin	403	115
Levothyroxine Sodium	Levothyroxine Sodium	392	114
Tamsulosin Hcl	Tamsulosin Hcl	389	109
Amlodipine Besylate	Amlodipine Besylate	353	103
Metformin Hcl	Metformin Hcl	253	77
Gabapentin	Gabapentin	239	83
Rosuvastatin Calcium	Rosuvastatin Calcium	228	65
Metoprolol Tartrate	Metoprolol Tartrate	210	60
Pradaxa	Dabigatran Etexilate Mesylate	208	66
Glipizide	Glipizide	203	62
Losartan Potassium	Losartan Potassium	183	52
Finasteride	Finasteride	181	49
Pantoprazole Sodium	Pantoprazole Sodium	181	62
Atenolol	Atenolol	163	49
Furosemide	Furosemide	163	73
Trazodone Hcl	Trazodone Hcl	163	50
Warfarin Sodium	Warfarin Sodium	163	45
Fluticasone Propionate	Fluticasone Propionate	157	69
Tramadol Hcl	Tramadol Hcl	150	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	148	48
Meloxicam	Meloxicam	148	45
Albuterol Sulfate Hfa	Albuterol Sulfate	142	65
Hydrochlorothiazide	Hydrochlorothiazide	142	44
Oxycodone Hcl	Oxycodone Hcl	123	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	122	18
Metformin Hcl Er	Metformin Hcl	121	37
Alendronate Sodium	Alendronate Sodium	116	33
Allopurinol	Allopurinol	116	39
Humulin N	Insulin Nph Human Isophane	113	41
Ozempic	Semaglutide	112	14
Duloxetine Hcl	Duloxetine Hcl	107	50
Arexvy	Rsvpref3 Antigen/As01e/Pf	106	106
Potassium Chloride	Potassium Chloride	99	32
Metoprolol Succinate	Metoprolol Succinate	96	31
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	95	26
Donepezil Hcl	Donepezil Hcl	91	32
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	27
Citalopram Hbr	Citalopram Hydrobromide	89	25
Mirtazapine	Mirtazapine	86	32
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	85	suppressed
Ezetimibe	Ezetimibe	84	23
Doxazosin Mesylate	Doxazosin Mesylate	80	23
Humulin R	Insulin Regular, Human	80	22
Prednisone	Prednisone	78	27
Jardiance	Empagliflozin	75	21
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	68	32
Celecoxib	Celecoxib	67	20
Sertraline Hcl	Sertraline Hcl	65	19
Wixela Inhub	Fluticasone Propion/Salmeterol	59	22
Clopidogrel	Clopidogrel Bisulfate	58	23
Fluoxetine Hcl	Fluoxetine Hcl	56	20
Lorazepam	Lorazepam	56	15
Eliquis	Apixaban	52	14
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	51	18
Carvedilol	Carvedilol	48	14
Azithromycin	Azithromycin	47	14
Shingrix	Varicella-Zoster Ge/As01b/Pf	47	47
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	45	45
Alprazolam	Alprazolam	44	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Lactulose	Lactulose	39	15
Spiriva Respimat	Tiotropium Bromide	39	12
Triamcinolone Acetonide	Triamcinolone Acetonide	39	26
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	14
Hydrocortisone	Hydrocortisone	35	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	35	14
Famotidine	Famotidine	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Digoxin	Digoxin	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	11
Acyclovir	Acyclovir	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	25	suppressed
Colchicine	Colchicine	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	17
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	12
Cefuroxime	Cefuroxime Axetil	22	12
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	21	21
Repatha Sureclick	Evolocumab	21	suppressed
Trospium Chloride	Trospium Chloride	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Naloxone Hcl	Naloxone Hcl	20	suppressed
Estradiol	Estradiol	19	suppressed
Modafinil	Modafinil	19	suppressed
Nitroglycerin	Nitroglycerin	19	11
Amoxicillin	Amoxicillin	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Nitroglycerin Patch	Nitroglycerin	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Cephalexin	Cephalexin	17	11
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Cartia Xt	Diltiazem Hcl	14	suppressed
Klor-Con 10	Potassium Chloride	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Alvesco	Ciclesonide	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Diazepam	Diazepam	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Nystatin	Nystatin	11	suppressed
Temazepam	Temazepam	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error